Silke B, Riddell J G
University Department of Therapeutics and Pharmacology, Queen's University of Belfast, UK.
Clin Auton Res. 1998 Jun;8(3):145-53. doi: 10.1007/BF02281119.
There is evidence that the processes regulating heart rate variations reflect non-linear complexity and show 'chaotic' determinism. Data analyses using non-linear methods may therefore reveal patterns not apparent with conventional statistical approaches. We have consequently investigated two non-linear methods, the Poincaré plot (scatterplot) and cardiac sequence (quadrant) analysis, and compared these with standard time-domain summary statistics, during a normal volunteer investigation of an agonist and antagonists of the cardiac beta-adrenoceptor. Under double-blind and randomized conditions (Latin square design), 12 normal volunteers received placebo, celiprolol (beta 1- and beta 2-adrenoceptor partial agonist), propranolol (beta 1- and beta 2-adrenoceptor antagonist), atenolol (beta 1-adrenoceptor antagonist) and combinations of these agents. Single oral doses of medication (at weekly intervals) were administered at 22:30 hours with sleeping heart rates recorded overnight. The long (SDNN, SDANN) and short-term (rmsSD) time-domain summary statistics were reduced by celiprolol--effects different from the unchanged or small increases after atenolol and propranolol alone. The Poincaré plot was constructed by plotting each RR interval against the preceding RR interval, but unlike previous descriptions of the method, an automated computer method, with a high level of reproducibility, was employed. Scatterplot length and area were reduced following celiprolol and different from the small increases after propranolol and atenolol. The geometric analysis of the scatterplots allowed width assessment (i.e. dispersion) at fixed RR intervals. Differences between the drugs were confined to the higher percentiles (i.e. 75% and 90% of scatterplot length: low heart rate). The long-term time-domain statistics (SDNN, SDANN) correlated best with scatterplot length and area whereas the short-term heart rate variability (HRV) indices (rmsSD), pNN50) correlated strongly with scatterplot width. Cardiac sequence analysis (differences between three adjacent beats; delta RR vs delta RRn+1) assessed the short-term patterns of cardiac acceleration and deceleration, four patterns are identified: +/+ (a lengthening sequencing), +/- or -/+ (balanced sequences), and finally -/- (a shortening sequence). A running count of events by quadrant, together with the average magnitude of the differences was computed. The beta-adrenoceptor partial agonist celiprolol increased acceleration sequences. The duration of beat-to-beat difference shortened after celiprolol; this contrasted with increased duration of beat-to-beat difference after propranolol and atenolol. These results demonstrated a shift towards sympathetic dominance after the beta-adrenoceptor partial agonist celiprolol contrasting in parasympathetic dominance after the beta-adrenoceptor antagonists propranolol and atenolol. These non-linear methods appear to be valuable tools to investigate HRV in health and in cardiovascular disease and to study the implications of alterations in autonomic control during therapeutic intervention.
有证据表明,调节心率变异性的过程反映了非线性复杂性,并显示出“混沌”确定性。因此,使用非线性方法进行数据分析可能会揭示传统统计方法无法显现的模式。在对心脏β-肾上腺素能受体激动剂和拮抗剂进行的正常志愿者研究中,我们研究了两种非线性方法,即庞加莱图(散点图)和心脏序列(象限)分析,并将其与标准时域汇总统计数据进行了比较。在双盲和随机条件下(拉丁方设计),12名正常志愿者接受了安慰剂、塞利洛尔(β1和β2肾上腺素能受体部分激动剂)、普萘洛尔(β1和β2肾上腺素能受体拮抗剂)、阿替洛尔(β1肾上腺素能受体拮抗剂)以及这些药物的组合。单剂量口服药物(每周一次)于22:30给药,并记录整夜的睡眠心率。塞利洛尔降低了长时(SDNN、SDANN)和短时(rmsSD)时域汇总统计数据——其效果与单独使用阿替洛尔和普萘洛尔后不变或小幅增加不同。庞加莱图是通过将每个RR间期与前一个RR间期进行绘图构建的,但与该方法之前的描述不同,我们采用了具有高度可重复性的自动化计算机方法。塞利洛尔给药后,散点图长度和面积减小,这与普萘洛尔和阿替洛尔给药后小幅增加不同。散点图的几何分析允许在固定RR间期评估宽度(即离散度)。药物之间的差异仅限于较高百分位数(即散点图长度的75%和90%:低心率)。长期时域统计数据(SDNN、SDANN)与散点图长度和面积的相关性最佳,而短时心率变异性(HRV)指标(rmsSD、pNN50)与散点图宽度密切相关。心脏序列分析(三个相邻搏动之间的差异;RR间期变化量与RR间期变化量n + 1)评估心脏加速和减速的短期模式,识别出四种模式: +/+(延长序列)、+/- 或 -/+(平衡序列),最后是 -/-(缩短序列)。计算每个象限事件的连续计数以及差异的平均大小。β-肾上腺素能受体部分激动剂塞利洛尔增加了加速序列。塞利洛尔给药后逐搏差异的持续时间缩短;这与普萘洛尔和阿替洛尔给药后逐搏差异持续时间增加形成对比。这些结果表明,β-肾上腺素能受体部分激动剂塞利洛尔给药后出现向交感神经优势的转变,而β-肾上腺素能受体拮抗剂普萘洛尔和阿替洛尔给药后出现副交感神经优势。这些非线性方法似乎是研究健康和心血管疾病中HRV以及研究治疗干预期间自主控制改变影响的有价值工具。